These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7535469)

  • 41. Neurotoxic effects of p-chloroamphetamine on the serotoninergic innervation of the trigeminal motor nucleus: a retrograde transport study.
    Fritschy JM; Lyons WE; Molliver ME; Grzanna R
    Brain Res; 1988 Nov; 473(2):261-70. PubMed ID: 2466523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Backward walking and circling: behavioural responses induced by drug treatments which cause simultaneous release of catecholamines and 5-hydroxytryptamine.
    Curzon G; Fernando JC; Lees AJ
    Br J Pharmacol; 1979 Aug; 66(4):573-9. PubMed ID: 465894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives.
    Mamounas LA; Mullen CA; O'Hearn E; Molliver ME
    J Comp Neurol; 1991 Dec; 314(3):558-86. PubMed ID: 1814975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia.
    Quock RM; Weick BG
    J Pharm Pharmacol; 1979 Jan; 31(1):27-32. PubMed ID: 32362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA; Takeda H; Cho AK; Howard SG
    Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood.
    Martín F; Artigas F
    J Neurochem; 1992 Sep; 59(3):1138-44. PubMed ID: 1379630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs.
    Gardier AM; Kaakkola S; Erfurth A; Wurtman RJ
    Brain Res; 1992 Aug; 588(1):67-74. PubMed ID: 1382807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines.
    Yuan J; Cord BJ; McCann UD; Callahan BT; Ricaurte GA
    J Pharmacol Exp Ther; 2002 Nov; 303(2):831-9. PubMed ID: 12388670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation rearing of rats alters release of 5-hydroxytryptamine and dopamine in the frontal cortex: an in vivo electrochemical study.
    Crespi F; Wright IK; Möbius C
    Exp Brain Res; 1992; 88(3):495-501. PubMed ID: 1375164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.
    Adell A; Sarna GS; Hutson PH; Curzon G
    Br J Pharmacol; 1989 May; 97(1):206-12. PubMed ID: 2720308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat.
    Ogren SO
    Pharmacol Biochem Behav; 1982 Jun; 16(6):881-95. PubMed ID: 7111347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine.
    Trulson ME; Jacobs BL
    Eur J Pharmacol; 1976 Mar; 36(1):149-54. PubMed ID: 131036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
    Xie T; Tong L; McLane MW; Hatzidimitriou G; Yuan J; McCann U; Ricaurte G
    Neuropsychopharmacology; 2006 Dec; 31(12):2639-51. PubMed ID: 16452989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats.
    Baker LE; Makhay MM
    Pharmacol Biochem Behav; 1996 Feb; 53(2):455-61. PubMed ID: 8808158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Adell A; Carceller A; Artigas F
    J Neurochem; 1993 May; 60(5):1673-81. PubMed ID: 7682600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry.
    Callaghan PD; Irvine RJ; Daws LC
    Neurochem Int; 2005 Oct; 47(5):350-61. PubMed ID: 15979209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
    Blier P; Serrano A; Scatton B
    Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of systemic phenylpropanolamine and fenfluramine on serotonin activity within rat paraventricular hypothalamus.
    McMahon LR; Wellman PJ
    Physiol Behav; 1996 Jan; 59(1):63-9. PubMed ID: 8848492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
    Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.